Kwality Pharmaceuticals Ltd — Important, 01-01-2026: Company Update

Kwality Pharmaceuticals' Board has approved the appointment of Mr. PreetMohinder Singh Bedi as an Additional Independent Director for a five-year term, subject to shareholder approval. Mr. Bedi brings over 28 years of extensive pharmaceutical industry experience, including a distinguished academic career as a Professor and Director at Guru Nanak Dev University. Recognized as a top 2% global scientist, his expertise in drug design, synthesis, and biologically active molecules is expected to significantly benefit the company's strategic direction and enhance governance. This appointment strengthens the board with deep industry and scientific acumen.